↓ Skip to main content

The circadian gene NPAS2 is a novel prognostic biomarker for breast cancer

Overview of attention for article published in Breast Cancer Research and Treatment, August 2009
Altmetric Badge

Mentioned by

wikipedia
1 Wikipedia page

Citations

dimensions_citation
63 Dimensions

Readers on

mendeley
50 Mendeley
Title
The circadian gene NPAS2 is a novel prognostic biomarker for breast cancer
Published in
Breast Cancer Research and Treatment, August 2009
DOI 10.1007/s10549-009-0484-0
Pubmed ID
Authors

Chunhui Yi, Lina Mu, Irene A. Rigault de la Longrais, Olga Sochirca, Riccardo Arisio, Herbert Yu, Aaron E. Hoffman, Yong Zhu, Dionyssios Katsaro

Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 50 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
United Kingdom 1 2%
United States 1 2%
Sweden 1 2%
Unknown 47 94%

Demographic breakdown

Readers by professional status Count As %
Researcher 9 18%
Student > Ph. D. Student 8 16%
Student > Bachelor 6 12%
Professor > Associate Professor 6 12%
Student > Master 4 8%
Other 7 14%
Unknown 10 20%
Readers by discipline Count As %
Agricultural and Biological Sciences 13 26%
Biochemistry, Genetics and Molecular Biology 10 20%
Medicine and Dentistry 9 18%
Neuroscience 2 4%
Business, Management and Accounting 1 2%
Other 2 4%
Unknown 13 26%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 3. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 13 April 2017.
All research outputs
#7,475,808
of 22,854,458 outputs
Outputs from Breast Cancer Research and Treatment
#1,656
of 4,659 outputs
Outputs of similar age
#37,189
of 110,645 outputs
Outputs of similar age from Breast Cancer Research and Treatment
#17
of 30 outputs
Altmetric has tracked 22,854,458 research outputs across all sources so far. This one is in the 44th percentile – i.e., 44% of other outputs scored the same or lower than it.
So far Altmetric has tracked 4,659 research outputs from this source. They typically receive a little more attention than average, with a mean Attention Score of 7.2. This one is in the 41st percentile – i.e., 41% of its peers scored the same or lower than it.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 110,645 tracked outputs that were published within six weeks on either side of this one in any source. This one is in the 18th percentile – i.e., 18% of its contemporaries scored the same or lower than it.
We're also able to compare this research output to 30 others from the same source and published within six weeks on either side of this one. This one is in the 6th percentile – i.e., 6% of its contemporaries scored the same or lower than it.